Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nam H Dang

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
BMC Cancer|February 3, 2011
Mechanisms of confluence-dependent expression of CD26 in colon cancer cell linesMasako Abe, Pamela A Havre, Yasuyo Urasaki, et al.
Biochemical and Biophysical Research Communications|April 23, 2016
Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomainsSayaka Nomura, Satoshi Iwata, Ryo Hatano, et al.
Modern Rheumatology|March 25, 2015
Modulation of immunological responses and amelioration of collagen-induced arthritis by the novel roxithromycin derivative 5-INoriko Otsuki, Satoshi Iwata, Taketo Yamada, et al.
Journal of Clinical Laboratory Analysis|April 2, 2014
Comparison of two commercial ELISAs against an in-house ELISA for measuring soluble CD26 in human serumKei Ohnuma, Tatsuhiko Saito, Ryou Hatano, et al.
Leukemia & Lymphoma|December 17, 2020
Reduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomesKelsey Pan, Aaron J Franke, William Paul Skelton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2015
Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytesKei Ohnuma, Ryo Hatano, Thomas M Aune, et al.
Cureus|March 20, 2020
Single-institution Retrospective Analysis of Prognostic Factors Influencing Very Late-onset Post-transplant Lymphoproliferative DisorderRohit Bishnoi, Jordan Minish, Aaron J Franke, et al.
Cancer Research|August 3, 2005
CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299Tsutomu Sato, Tadanori Yamochi, Toshiko Yamochi, et al.
British Journal of Haematology|June 6, 2003
T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibitionNam H Dang, Ugur Aytac, Kazuya Sato, et al.
Cancer|April 9, 2005
Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experienceMaricer P Escalón, Nina S Liu, Ying Yang, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
BMC Cancer|February 3, 2011
Mechanisms of confluence-dependent expression of CD26 in colon cancer cell linesMasako Abe, Pamela A Havre, Yasuyo Urasaki, et al.
Biochemical and Biophysical Research Communications|April 23, 2016
Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomainsSayaka Nomura, Satoshi Iwata, Ryo Hatano, et al.
Modern Rheumatology|March 25, 2015
Modulation of immunological responses and amelioration of collagen-induced arthritis by the novel roxithromycin derivative 5-INoriko Otsuki, Satoshi Iwata, Taketo Yamada, et al.
Journal of Clinical Laboratory Analysis|April 2, 2014
Comparison of two commercial ELISAs against an in-house ELISA for measuring soluble CD26 in human serumKei Ohnuma, Tatsuhiko Saito, Ryou Hatano, et al.
Leukemia & Lymphoma|December 17, 2020
Reduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomesKelsey Pan, Aaron J Franke, William Paul Skelton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2015
Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytesKei Ohnuma, Ryo Hatano, Thomas M Aune, et al.
Cureus|March 20, 2020
Single-institution Retrospective Analysis of Prognostic Factors Influencing Very Late-onset Post-transplant Lymphoproliferative DisorderRohit Bishnoi, Jordan Minish, Aaron J Franke, et al.
Cancer Research|August 3, 2005
CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299Tsutomu Sato, Tadanori Yamochi, Toshiko Yamochi, et al.
British Journal of Haematology|June 6, 2003
T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibitionNam H Dang, Ugur Aytac, Kazuya Sato, et al.
Cancer|April 9, 2005
Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experienceMaricer P Escalón, Nina S Liu, Ying Yang, et al.
Pageof 13